Santiá, PaulaJansana Riera, AnnaDel Cura, Maria IsabelPadilla-Ruiz, MariaDomingo, LaiaLouro, JavierComas Serrano, MercèSanz Cuesta, TeresaDuarte Salles, Talita, 1985-Redondo, MaximinoIbañez, BertaPrados-Torres, AlexandraCastells, XavierSala Serra, MariaSURBCAN group2022-10-112022-10-112022Santiá P, Jansana A, Del Cura I, Padilla-Ruiz M, Domingo L, Louro J, et al. Adherence of long-term breast cancer survivors to follow-up care guidelines: a study based on real-world data from the SURBCAN cohort. Breast Cancer Res Treat. 2022 Jun; 193(2): 455-65. DOI: 10.1007/s10549-022-06563-x0167-6806http://hdl.handle.net/10230/54352Purpose: to identify adherence to follow-up recommendations in long-term breast cancer survivors (LTBCS) of the SURBCAN cohort and to identify its determinants, using real-world data. Methods: we conducted a retrospective study using electronic health records from 2012 to 2016 of women diagnosed with incident breast cancer in Spain between 2000 and 2006 and surviving at least 5 years. Adherence to basic follow-up recommendations, adherence according to risk of recurrence, and overall adherence were calculated based on attendance at medical appointments and imaging surveillance, by year of survivorship. Logistic regression models were fitted to depict the association between adherence and its determinants. Results: a total of 2079 LTBCS were followed up for a median of 4.97 years. Of them, 23.6% had survived ≥ 10 years at baseline. We estimated that 79.5% of LTBCS were overall adherent to at least one visit and one imaging test. Adherence to recommendations decreased over time and no differences were found according to recurrence risk. Determinants of better overall adherence were diagnosis in middle age (50-69 years old), living in a more-deprived area, having fewer years of survival, receiving primary treatment, and being alive at the end of follow-up. Conclusion: we identified women apparently not complying with surveillance visits and tests. Special attention should be paid to the youngest and eldest women at diagnosis and to those with longer survival.application/pdfengThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.info:eu-repo/semantics/articlehttp://dx.doi.org/10.1007/s10549-022-06563-xAftercareBreast neoplasms Cancer survivors; Guideline adherence; Long-term survivors; MammographyCancer survivorsGuideline adherenceLong-term survivorsMammographyinfo:eu-repo/semantics/openAccess